Tracking fructose 1,6-bisphosphate dynamics in liver cancer cells using a fluorescent biosensor

HYlight is a genetically encoded fluorescent biosensor that ratiometrically monitors fructose 1,6-bisphosphate (FBP), a key glycolytic metabolite. Given the role of glucose in liver cancer metabolism, we expressed HYlight in human liver cancer cells and primary mouse hepatocytes. Through in vitro, in silico, and in cellulo experiments, we showed HYlight’s ability to monitor FBP changes linked to glycolysis, not gluconeogenesis. HYlight’s affinity for FBP was ∼1 μM and stable within physiological pH range. HYlight demonstrated weak binding to dihydroxyacetone phosphate, and its ratiometric response was influenced by both ionic strength and phosphate. Therefore, simulating cytosolic conditions in vitro was necessary to establish a reliable correlation between HYlight’s cellular responses and FBP concentrations. FBP concentrations were found to be in the lower micromolar range, far lower than previous millimolar estimates. Altogether, this biosensor approach offers real-time monitoring of FBP concentrations at single-cell resolution, making it an invaluable tool for the understanding of cancer metabolism. [Display omitted] •HYlight tracks real-time fructose 1,6-bisphosphate dynamics at single-cell resolution•HYlight’s cellular responses are aligned with glycolysis changes rather than gluconeogenesis•HYlight’s cellular responses correlate with fructose 1,6-bisphosphate concentrations•Fructose 1,6-bisphosphate levels in liver cancer cells are in the low micromolar range Biochemistry methods; Cancer; Metabolomics.